SB-204990 | m-entrepreneurship.com

Product Name :
SB-204990

Search keywords :
SB 204990

drugId :
null

Target Vo:
ATP-citrate synthase

Target Vo Short Name :
ACLY

Moa_Name:
ATP-citrate synthase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Smithkline Beecham

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Hyperlipidemias

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-ATF2 (Thr71) Rabbit mAb Technical Information
Vedolizumab Biological Activity
FYN Antibody: FYN Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 61 kDa, targeting to FYN. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts